SCRIBE THERAPEUTICS (SCTX) Stock Price, News & Analysis
SCTX
NASDAQ
Company Description
SCRIBE THERAPEUTICS (NASDAQ: SCTX) is classified in the biotechnology industry within the Healthcare sector.
This page collects what Stock Titan holds for SCTX, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
$18.00
-5.11%
0.97
Last updated: July 28, 2026 at 16:00
-
Performance 1 year
$0.0
16.2M
SCRIBE THERAPEUTICS (SCTX) stock last closed at $18.06.
Latest News
SCRIBE THERAPEUTICS has 2 recent news articles, with the latest published yesterday. Key topics include IPO, private placement, offering. View all SCTX news →
SEC Filings
Financial Highlights
—
Revenue (latest FY)
—
Net Income (latest FY)
—
Operating Cash Flow
Upcoming Events
Short Interest History
Last 12 Months
Days to Cover History
Last 12 Months
SCTX Company Profile & Sector Positioning
SCRIBE THERAPEUTICS (SCTX) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Frequently Asked Questions
What is the current stock price of SCRIBE THERAPEUTICS (SCTX)?
The current stock price of SCRIBE THERAPEUTICS (SCTX) is $18.06 as of July 28, 2026.